According to the latest report published by Data Bridge Market Research, the U.S. Internal Neuromodulation Devices Market  CAGR Value The U.S. Internal Neuromodulation Devices Market size was valued at USD 3.11 billion in 2025 and is expected to reach USD 7.27 billion by 2033, at a CAGR of 11.20% during the forecast period In this...

The United States healthcare ecosystem is witnessing a notable shift toward advanced neuromodulation therapies as the burden of neurological and psychiatric disorders continues to rise. Increasing cases of epilepsy, treatment-resistant depression, and chronic migraine are driving demand for innovative therapeutic approaches that go beyond traditional pharmaceuticals. Vagus nerve stimulation has...